Although the correlation between copeptin and trauma outcomes is still a topic of ongoing debate, there is growing evidence of its potential as a biomarker for trauma and post-trauma diseases to assist in determining the severity, prognosis, and outcome of trauma patients. This evidence concerns the gene AVP and injury.